Cardiac organ-limited amyloidosis (Q104617): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Trata-se de condição cardíaca em uma categoria de amiloidose, a deposição de amiloide clinicamente é limitada a um órgão. É comparada à amiloidose sistêmica e pode ser causada por vários tipos diferentes de amiloide. Em quase todas as patologias específicas de órgãos, há um debate significativo sobre se as placas amiloides são o agente causal da doença ou consequência a jusante de um agente idiopático comum.
description / endescription / en
 
This refers to a cardiac condition in a category of amyloidosis where the distribution can be associated primarily with a single organ. It is contrasted to systemic amyloidosis, and it can be caused by several different types of amyloid. In almost all of the organ-specific pathologies, there is significant debate as to whether the amyloid plaques are the causal agent of the disease or instead a downstream consequence of a common idiopathic agent.

Revision as of 10:28, 17 August 2026

This refers to a cardiac condition in a category of amyloidosis where the distribution can be associated primarily with a single organ. It is contrasted to systemic amyloidosis, and it can be caused by several different types of amyloid. In almost all of the organ-specific pathologies, there is significant debate as to whether the amyloid plaques are the causal agent of the disease or instead a downstream consequence of a common idiopathic agent.
Language Label Description Also known as
default for all languages
ID_300580975
    English
    Cardiac organ-limited amyloidosis
    This refers to a cardiac condition in a category of amyloidosis where the distribution can be associated primarily with a single organ. It is contrasted to systemic amyloidosis, and it can be caused by several different types of amyloid. In almost all of the organ-specific pathologies, there is significant debate as to whether the amyloid plaques are the causal agent of the disease or instead a downstream consequence of a common idiopathic agent.

      Statements